As of 2024-12-13, the Relative Valuation of Prometheus Biosciences Inc (RXDX) is (58.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 199.92 USD, the upside of Prometheus Biosciences Inc based on Relative Valuation is -129.2%.
The range of the Relative Valuation is (60.71) - (61.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 24.4x | 17.5x |
| Forward P/E multiples | 19.3x - 19.6x | 19.6x |
| Fair Price | (60.71) - (61.72) | (58.41) |
| Upside | -130.4% - -130.9% | -129.2% |
| Date | P/E |